41 product specifications have a maximum drop of 99%!

On September 7, the Ganshan-Shaanxi Alliance announced the official selection results for the 2021 drug centralized procurement.

According to the Gansu Provincial Medical Insurance Bureau, the selected price has dropped by an average of 58.

Official statistics show that there are a total of 30 varieties and 41 product specifications selected for this purchase of drugs, mainly involving antibacterial, cardiovascular system, nervous system, digestive system, respiratory system and other therapeutic disciplines, mainly in injection formulations

review

On August 24, the Ganshan-Shaanxi Alliance Joint Procurement Office announced the results of the planned selection of 2021 centralized drug procurement.

The Gansu-Shaanxi Alliance is led by Gansu Province and combined with Shaanxi Medical Institutions to form an inter-provincial volume procurement alliance to carry out centralized volume procurement of medicines

Unlike most inter-provincial alliances, this time the Ganshan-Shaanxi alliance chose to purchase generic drugs that have not passed the consistency evaluation for mass purchases.

In addition, from the release of the procurement documents to the company's quotation, if a purchased product is identified as a reference preparation by the relevant department or passed the consistency evaluation of a generic drug, the product will no longer be included in the centralized procurement

According to the requirements of the bid, the drugs participating in this centralized procurement of quantities are not distinguished by quality levels.

The following is a summary table of the selected results: